A 4-year-old boy with KS developed mycoplasma pneumonia requiring hospitalization. He exhibited depressed mental status, refractory status epilepticus, and paroxysmal sympathetic hyperactivity. MRI brain showed restricted diffusion and T2 hyperintensities in the bilateral mesial temporal lobes. CSF was normal.
He underwent extensive evaluation for infectious, inflammatory, and metabolic disorders. Subsequently, he was found to be positive for serum CASPR-2 antibodies (CSF antibody not assessed). He received high dose IV steroids and plasma exchange without neurologic improvement. Repeat CSF showed mildly elevated protein to 47 mg/dl and negative CSF CASPR-2 antibodies.
He received intensive, multidisciplinary inpatient rehabilitation and was followed closely by physiatrists, pediatric hospitalists, neuropsychologists, palliative care clinicians, nutritionists, and physical, speech, and occupational therapists. Due to lack of improvement, he received rituximab and monthly IVIG. Six months later, he remained non-verbal with minimal purposeful movements.